Everest Pharmaceuticals Ltd. is a Bangladesh-based pharmaceutical company involved in the development and manufacturing of medicines across several therapeutic areas. The company’s portfolio includes specialized products in oncology, hematology, nephrology, virology, and other healthcare categories. Its product range includes Lenvaxen 4 mg and Lenvaxen 10 mg, containing lenvatinib mesylate, an oral medicine used under specialist medical supervision. Everest Pharmaceuticals lists both Lenvaxen strengths in its official product portfolio.
Manufacturing Facilities and Quality Focus
Everest Pharmaceuticals operates its main manufacturing facility at BSCIC Kanchpur, Soanargaon, Narayanganj, Bangladesh. According to the company, the facility is designed to manufacture different pharmaceutical dosage forms, including tablets, capsules, creams, ointments, liquids, and pre-filled syringes. The company also describes its manufacturing site as a GMP-compliant facility.
Quality is an important part of Everest Pharmaceuticals’ manufacturing approach. The company states that it follows cGMP principles and emphasizes qualified personnel, controlled processes, and continuous improvement to support consistent product quality.
Everest Pharmaceuticals Head Office and Plant
The company’s head office is located at Rahman’s Regnum Centre, 191/1, Bir Uttam Mir Shawkat Sarak, Tejgaon Commercial Area, Dhaka-1208, Bangladesh. Its principal manufacturing plant is situated at B-33, 45 & 46, BSCIC, Kanchpur, Narayanganj-1430, Bangladesh.
With a focus on specialized and technology-driven pharmaceutical products, Everest Pharmaceuticals aims to expand access to medicines for patients in Bangladesh and international markets. Its manufacturing capabilities and emphasis on quality make the company an established name in Bangladesh’s pharmaceutical sector.